On Cost Effectiveness and Sample Size in Clinical Trials

Author： Augustinus A.M. Hart   Marcel G.W. Dijkgraaf  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.10, 2004-01, pp. : 685-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On Cost Effectiveness and Sample Size in Clinical Trials. The Author's Reply

By Martin E. Backhouse  

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 688-689

Adis International

Access to resources Recommend Favorite

Sample Size Determination for Cost-Effectiveness Trials

By Willan Andrew R.  

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 933-949

Adis International

Access to resources Recommend Favorite

Use of Randomised Controlled Trials for Producing Cost-Effectiveness Evidence: Potential Impact of Design Choices on Sample Size and Study Duration

By Backhouse M.E.  

PharmacoEconomics, Vol. 20, Iss. 15, 2002-01 ,pp. : 1061-1077

Adis International

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 1)

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 189-198

Adis International

Access to resources Recommend Favorite

Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis

By Walter S.D.   Gafni Amiram   Birch Stephen  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 455-466

Adis International

Access to resources Recommend Favorite